TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

All Recent Buys Recent Sells
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
IRON Bitterman Kevin Director 09/02/2026 Verkauf 80.17 26,542 2,127,872 Form 4
DSX Diana Shipping Inc. 10% Owner 09/02/2026 Verkauf 26.73 75,000 2,004,750 Form 4
CRCT Ashish Arora Chief Executive Officer 09/02/2026 Verkauf 5.79 60,000 347,640 Form 4
CCAP Fidelity & Guaranty Life Insurance Co 10% Owner 09/02/2026 Verkauf 10.44 45,000 470,016 Form 4
CLPT Burnett Joseph CEO and President 09/02/2026 Optionsausübung 3.47 12,517 43,434 Form 4
CRCL Fox-Geen Jeremy Chief Financial Officer 09/02/2026 Verkauf 87.87 8,120 713,504 Form 4
CRCL Razzaghi Hossein Chief Commercial Officer 09/02/2026 Verkauf 87.87 7,458 655,334 Form 4
CRCL Schulz Tamara L Chief Accounting Officer 09/02/2026 Verkauf 87.87 1,194 104,917 Form 4
CRT Oliver Eric L 10% Owner 09/02/2026 Kauf 10.63 2,289 24,332 Form 4
CORT Maduck Sean See Remarks 09/02/2026 Steuer-Abgabe 113.38 117 13,265 Form 4
CORT Mokari Atabak Chief Financial Officer 09/02/2026 Steuer-Abgabe 113.38 102 11,565 Form 4
CORT Robb Gary Charles Chief Business Officer 09/02/2026 Steuer-Abgabe 113.38 91 10,318 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 115.44 1,225 141,413 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 114.58 5,621 644,042 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 113.72 1,606 182,632 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 112.40 974 109,474 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 111.37 1,537 171,181 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 110.70 23,770 2,631,349 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 109.35 23,600 2,580,674 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Optionsausübung 21.63 58,333 1,261,743 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Steuer-Abgabe 113.38 102 11,565 Form 4
CORT Lyon Joseph Douglas See Remarks 09/02/2026 Steuer-Abgabe 113.38 72 8,163 Form 4
CCZ Roberts Brian L Chairman of Board & Co-CEO 09/02/2026 Schenkung — 101,900 — Form 4
CMCSA Roberts Brian L Chairman of Board & Co-CEO 09/02/2026 Schenkung — 101,900 — Form 4
CCOI Weed Thaddeus Gerard VICE PRESIDENT, CFO 09/02/2026 Verkauf 9.37 4,850 45,445 Form 4
CHKP Chelouche Yoav Director 09/02/2026 Zuteilung — 1,120 — Form 4
CHKP Ozer-Armon Tzipi Director 09/02/2026 Zuteilung — 1,120 — Form 4
CHKP Shavit Shenhav Tal Director 09/02/2026 Zuteilung — 1,120 — Form 4
CHKP Zafrir Nadiv CEO 09/02/2026 Zuteilung — 44,812 — Form 4
CHKP Smith Jill D. Director 09/02/2026 Zuteilung — 1,120 — Form 4
CHKP Ungerman Jerry T Director 09/02/2026 Zuteilung — 1,120 — Form 4
CHKP Gruber Dafna Director 09/02/2026 Zuteilung — 1,120 — Form 4
CATY Sun Richard Director 09/02/2026 Verkauf 62.32 1,000 62,315 Form 4
AI Siebel Thomas M CEO and Chairman of the Board 09/02/2026 Verkauf 10.30 16,890 173,967 Form 4
VTOL Solus Alternative Asset Management LP See Below 09/02/2026 Verkauf 45.68 12,045 550,253 Form 4
BWB Juran David B. Director 09/02/2026 Verkauf 21.50 623 13,395 Form 4
BORR Crowe Jason Philip SVP - Commercial 09/02/2026 Verkauf 4.55 16,495 75,052 Form 4
BORR Lee Charles (Chuck) SVP - General Counsel 09/02/2026 Verkauf 4.80 10,538 50,588 Form 4
ECAT Saba Capital Management, L.P. 10% Owner 09/02/2026 Verkauf 15.28 53,758 821,422 Form 4
BBNX Russell Steven Jon Chief Medical Officer 09/02/2026 Verkauf 19.11 4,221 80,676 Form 4
BBNX Saint Sean President & CEO 09/02/2026 Verkauf 19.11 16,867 322,381 Form 4
BBNX Feider Stephen Chief Financial Officer 09/02/2026 Verkauf 19.11 6,675 127,580 Form 4
BBNX Mensinger Mike Chief Product Officer 09/02/2026 Verkauf 19.11 4,375 83,620 Form 4
BBNX Hopman Mark Chief Commercial Officer 09/02/2026 Verkauf 19.11 5,327 101,815 Form 4
BAND Ross Kade Chief Information Officer 09/02/2026 Verkauf 49.29 753 37,115 Form 4
BAND Ross Kade Chief Information Officer 09/02/2026 Verkauf 48.50 1,151 55,827 Form 4
BAND Ross Kade Chief Information Officer 09/02/2026 Verkauf 47.54 2,096 99,643 Form 4
BAND Raiford Daryl E Chief Financial Officer 09/02/2026 Verkauf 49.97 3,291 164,443 Form 4
BAND Raiford Daryl E Chief Financial Officer 09/02/2026 Verkauf 48.99 1,400 68,582 Form 4
BAND Raiford Daryl E Chief Financial Officer 09/02/2026 Verkauf 47.74 2,536 121,057 Form 4
BCO Cook Kristen Williams EVP & CLO 09/02/2026 Steuer-Abgabe 107.47 729 78,346 Form 4
BRID Bridgford Allan Jr. Consultant 09/02/2026 Kauf 6.15 914 5,621 Form 4
BSX O'Connor Padraig Andrew EVP, Global Operations 09/02/2026 Steuer-Abgabe 48.37 567 27,426 Form 4
BSX O'Connor Padraig Andrew EVP, Global Operations 09/02/2026 Optionsausübung — 1,171 — Form 4
BMRN Davis George Eric EVP, Chief Legal Officer 09/02/2026 Verkauf 66.28 17,557 1,163,748 Form 4
BETA Stone Michael Robert Director 09/02/2026 Kauf 19.19 13,125 251,810 Form 4
BDX Roque Vitor EVP & Chief Financial Officer 09/02/2026 Steuer-Abgabe — 190 — Form 4
BAX Hider Andrew P. President and CEO 09/02/2026 Steuer-Abgabe 25.70 54,276 1,394,893 Form 4
BAX Foster Julie President, Front Line Care 09/02/2026 Steuer-Abgabe 25.70 2,098 53,919 Form 4
AUTL Piccina Cintia U.S. CCO & Country Gen Manager 09/02/2026 Verkauf 2.34 6,713 15,682 Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?